China's Innovent Biologics Secures Over $300 Million Investment From Sanofi

China’s Innovent Biologics Secures Over $300 Million Investment From Sanofi

(Reuters) – Innovent Biologics Inc said on Friday Paris-based Sanofi SA would invest HK$2.42 billion ($307.88 million) in the biopharmaceutical group to jointly develop two cancer drugs in China. The all-cash investment by Sanofi unit Sanofi Foreign Participations B.V. will be at a price of HK$42.42 per Innovent share, representing a premium of about 29%…

Read More
Warner Bros. Discovery Reports $3.4 Billion Net Loss, Revenue Slips

Warner Bros. Discovery Reports $3.4 Billion Net Loss, Revenue Slips

(Reuters) -Warner Bros. Discovery Inc on Thursday reported a second-quarter net loss of $3.4 billion and a slight decline in revenue, as the newly merged company reconfigures overlapping businesses from WarnerMedia and Discovery. The company, which reported combined results for the first time, also disclosed 92.1 million streaming video subscribers. The net loss includes about…

Read More
Advisory Firm ISS Urges Monro Shareholders To Vote Against Board Members

Advisory Firm ISS Urges Monro Shareholders To Vote Against Board Members

By Svea Herbst-Bayliss (Reuters) -Monro Inc shareholders should vote against all five of its board directors because the U.S. auto service company did not take action to loosen the grip of its controlling investor, shareholder advisory firm ISS said on Wednesday. Eighty-eight percent of Morno’s common shareholders supported a proposal last year to give each…

Read More